Surmodics | SRDX - Capital Ordinário





Capital Ordinário Alterar Data
Abbott USD 1.74B 23.39B 2025-09
Align Technology USD 71.62M 133K 2026-03
Anika Therapeutics USD 13.89M 532K 2025-12
Arrowhead Research USD 137.39M 1.69M 2025-12
Artivion USD 47.84M 468K 2025-12
Baxter International USD 516.45M 2.17M 2026-03
Boston Scientific USD 1.48B 2.66M 2025-12
EDAP TMS EUR 37.39M 0 2025-09
Edwards Lifesciences USD 580.7M 0 2025-12
Haemonetics USD 46.83M 82K 2025-12
Heron Therapeutics USD 188.31M 4.99M 2025-12
J&J USD 2.41B 1.74M 2025-12
Merit Medical Systems USD 59.65M 231K 2026-03
Mesa Laboratories USD 349.53M 3.53M 2024-09
Nektar Therapeutics USD 20.38M 20.36M 2025-12
Option Care Health USD 156.99M 130K 2026-03
Stryker USD 382.98M 584K 2026-03
Surmodics USD 14.3M 13.58M 2025-06
Trinity Biotech USD 385.2M 382.82M 2025-06